Literature DB >> 2943330

Lymphoepithelioid lymphoma (Lennert's lymphoma) is a monoclonal proliferation of helper/inducer T cells.

A C Feller, G H Griesser, T W Mak, K Lennert.   

Abstract

Lymphoepithelioid lymphoma (Lennert's lymphoma) was first described as a special variant of Hodgkin's disease. This lesion is characterized by a high percentage of epithelioid and T cells and rarely contains the classical Hodgkin's/Reed-Sternberg cells. Cytogenetic abnormalities indicate that Lennert's lymphoma is of T cell origin. In the present study, immunohistochemical investigation of four cases of Lennert's lymphoma revealed two major cell populations of T cells that predominantly express the helper-inducer phenotype and Ki-M6- and Ki-M8-positive macrophages and epithelioid cells. Double-staining experiments for the detection of cell surface antigens and the proliferation-associated antigen Ki67 showed that only the CD4-positive cells (helper-inducer T cells) were proliferating. Examination of the DNA of these Lennert's lymphoma samples also indicated that monoclonal rearrangement of the T cell receptor beta-chain genes has occurred, whereas the immunoglobulin heavy- and kappa-chain genes remained in germline configuration. Our results strongly suggest that Lennert's lymphoma is a CD4-positive T cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943330

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells.

Authors:  Eva Geissinger; Tobias Odenwald; Seung-Sook Lee; Irina Bonzheim; Sabine Roth; Peter Reimer; Martin Wilhelm; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

Review 2.  Peripheral T-cell lymphoma.

Authors:  S Watanabe; K Mukai; M Shimoyama
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

Review 3.  Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification.

Authors:  T Suchi; K Lennert; L Y Tu; M Kikuchi; E Sato; A G Stansfeld; A C Feller
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

4.  Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy.

Authors:  A C Feller; H Griesser; C V Schilling; H H Wacker; F Dallenbach; H Bartels; R Kuse; T W Mak; K Lennert
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

5.  Identification of the tumor cells in peripheral T-cell lymphomas by combined polymerase chain reaction-based T-cell receptor beta spectrotyping and immunohistological detection with T-cell receptor beta chain variable region segment-specific antibodies.

Authors:  Eva Geissinger; Irina Bonzheim; László Krenács; Sabine Roth; Philipp Ströbel; German Ott; Peter Reimer; Martin Wilhelm; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

6.  Cytologic findings of peripheral T-cell lymphoma (PTCL) with high epitheloid cell content (Lennert's lymphoma) in imprint smear. A case report.

Authors:  Yahya Daneshbod
Journal:  Cytojournal       Date:  2006-02-06       Impact factor: 2.091

Review 7.  Second malignancies in Hodgkin's disease: A review of the literature and report of a case with a secondary Lennert's lymphoma.

Authors:  Ernst Jg Norval; Erich J Raubenheimer
Journal:  J Oral Maxillofac Pathol       Date:  2014-09

8.  Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.

Authors:  Brigitte Senechal; Gaelle Elain; Eric Jeziorski; Virginie Grondin; Natacha Patey-Mariaud de Serre; Francis Jaubert; Kheira Beldjord; Arielle Lellouch; Christophe Glorion; Michel Zerah; Pierre Mary; Mohammed Barkaoui; Jean Francois Emile; Liliane Boccon-Gibod; Patrice Josset; Marianne Debré; Alain Fischer; Jean Donadieu; Frederic Geissmann
Journal:  PLoS Med       Date:  2007-08       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.